Product Information
FT DUAL ACTION PAIN 250-125 MG is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1058 per EA under NDC 70677127401. Its NADAC has been published 77 times since Mar 5, 2025.
FDA first approved this application on Feb 28, 2023.
Strength
250; 125 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677127401
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA214836FDA Approved
2/28/2023
On Market Since
11/20/2024
Pharmacological Classes
Price Statistics
The NADAC for FT DUAL ACTION PAIN 250-125 MG has been published 77 times since Mar 5, 2025, and over the history we have for it it has risen 16.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1058 per EA |
|---|---|
| All-time high | $0.1086 (Jul 16, 2025) |
| All-time low | $0.0839 (Apr 22, 2026) |
| 52-week high | $0.1058 |
| 52-week low | $0.0839 |
| Median price | $0.0906 |
| Average price | $0.0927 |
| Largest weekly change | +11.7% (May 21, 2025) |
| Weeks tracked | 77 |
| Tracking since | Mar 5, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FT DUAL ACTION PAIN 250-125 MG?
The current National Average Drug Acquisition Cost (NADAC) for FT DUAL ACTION PAIN 250-125 MG, manufactured by Strategic Sourcing Services LLC, is $0.1058 per EA (NDC 70677127401), effective Aug 19, 2026.
How has the price of FT DUAL ACTION PAIN 250-125 MG changed over time?
Over the history we have for it, the NADAC for FT DUAL ACTION PAIN 250-125 MG has risen 16.5%. It has been tracked across 77 weekly CMS publications since Mar 5, 2025.
What are the highest and lowest recorded NADAC prices for FT DUAL ACTION PAIN 250-125 MG?
Since Mar 5, 2025, the NADAC for FT DUAL ACTION PAIN 250-125 MG has ranged from a low of $0.0839 (Apr 22, 2026) to a high of $0.1086 (Jul 16, 2025), with a median of $0.0906 per EA.
Are there cheaper alternatives to FT DUAL ACTION PAIN 250-125 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FT DUAL ACTION PAIN 250-125 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures FT DUAL ACTION PAIN 250-125 MG?
FT DUAL ACTION PAIN 250-125 MG (NDC 70677127401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.